Detalhe da pesquisa
1.
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease.
Am J Hematol
; 95(9): E242-E244, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472611
2.
PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity.
Pediatr Blood Cancer
; 61(1): 171-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24038960
3.
Diagnostic challenges between takotsubo cardiomyopathy and acute myocardial infarction-where is the emergency?: a literature review.
Int J Emerg Med
; 17(1): 22, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360558
4.
PedsQL™ sickle cell disease module: feasibility, reliability, and validity.
Pediatr Blood Cancer
; 60(8): 1338-44, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23441057